NYSE:TMO - Thermo Fisher Scientific Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $542.26
  • Forecasted Upside: 2.45 %
  • Number of Analysts: 19
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 18 Buy Ratings
  • 0 Strong Buy Ratings
$529.28
▼ -2.98 (-0.56%)

This chart shows the closing price for TMO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Thermo Fisher Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TMO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TMO

Analyst Price Target is $542.26
▲ +2.45% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for Thermo Fisher Scientific in the last 3 months. The average price target is $542.26, with a high forecast of $600.00 and a low forecast of $450.00. The average price target represents a 2.45% upside from the last price of $529.28.

This chart shows the closing price for TMO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 19 polled investment analysts is to buy stock in Thermo Fisher Scientific. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/2/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 18 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 18 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2021
  • 0 strong buy ratings
  • 18 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 18 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/19/2021SVB LeerinkReiterated RatingOutperformLow
7/16/2021BenchmarkInitiated CoverageBuy$580.00Medium
7/12/2021KeyCorpBoost Price TargetOverweight$520.00 ➝ $555.00Low
6/23/2021Robert W. BairdBoost Price TargetPositive ➝ Outperform$545.00 ➝ $550.00Low
6/15/2021The Goldman Sachs GroupLower Price TargetBuy$590.00 ➝ $530.00Low
5/3/2021Robert W. BairdReiterated RatingBuyLow
4/16/2021Evercore ISIBoost Price TargetOutperform$525.00 ➝ $540.00Low
3/29/2021UBS GroupLower Price TargetBuy$588.00 ➝ $560.00Low
3/18/2021KeyCorpUpgradeSector Weight ➝ Overweight$520.00Low
3/8/2021BarclaysInitiated CoverageOverweight$525.00N/A
3/2/2021BarclaysInitiated CoverageOverweight$525.00Medium
2/3/2021BTIG ResearchBoost Price TargetBuy$540.00 ➝ $590.00High
2/2/2021CitigroupBoost Price TargetBuy$500.00 ➝ $530.00Low
2/2/2021Stifel NicolausBoost Price TargetBuy$530.00 ➝ $600.00Low
2/2/2021CowenBoost Price TargetOutperform$525.00 ➝ $585.00Low
2/2/2021Morgan StanleyBoost Price TargetOverweight$535.00 ➝ $575.00Low
2/2/2021UBS GroupBoost Price TargetPositive ➝ Buy$566.00 ➝ $588.00Low
2/2/2021SVB LeerinkBoost Price TargetOutperform$525.00 ➝ $560.00Low
1/12/2021Credit Suisse GroupBoost Price Target$556.00 ➝ $580.00High
1/8/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$490.00 ➝ $556.00Medium
12/16/2020Smith Barney CitigroupDowngradeBuy ➝ NeutralHigh
12/2/2020Credit Suisse GroupBoost Price TargetNeutral$488.00 ➝ $490.00Low
12/2/2020Robert W. BairdBoost Price TargetOutperform$512.00 ➝ $523.00Low
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$570.00Low
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$550.00High
10/27/2020Needham & Company LLCBoost Price TargetBuy$477.00 ➝ $539.00Low
10/22/2020BTIG ResearchBoost Price TargetPositive ➝ Buy$475.00 ➝ $540.00High
10/22/2020Robert W. BairdBoost Price TargetOutperform$481.00 ➝ $512.00High
10/22/2020Credit Suisse GroupBoost Price TargetNeutral$432.00 ➝ $488.00High
10/22/2020Morgan StanleyBoost Price TargetOverweight$485.00 ➝ $535.00High
10/22/2020SVB LeerinkBoost Price TargetOutperform$470.00 ➝ $525.00High
10/5/2020JPMorgan Chase & Co.Boost Price TargetOverweight$460.00 ➝ $480.00High
9/30/2020Atlantic SecuritiesInitiated CoverageOverweight$494.00Medium
9/17/2020Needham & Company LLCBoost Price TargetBuy$468.00 ➝ $477.00Low
9/14/2020Morgan StanleyInitiated CoverageOverweight$485.00Low
9/11/2020Bank of AmericaBoost Price TargetBuy$460.00 ➝ $480.00Low
9/11/2020Credit Suisse GroupBoost Price TargetNeutral$425.00 ➝ $432.00Low
9/11/2020SVB LeerinkBoost Price TargetOutperform$455.00 ➝ $470.00Medium
9/11/2020CitigroupBoost Price TargetBuy$471.00 ➝ $485.00Medium
8/21/2020Credit Suisse GroupBoost Price TargetNeutral$405.00 ➝ $425.00Medium
8/20/2020JPMorgan Chase & Co.Reiterated RatingOverweight$460.00Low
8/13/2020Needham & Company LLCInitiated CoverageBuy$468.00Low
7/27/2020ArgusBoost Price Target$370.00 ➝ $450.00Low
7/23/2020Robert W. BairdBoost Price Target$352.00 ➝ $436.00Low
7/23/2020Needham & Company LLCBoost Price TargetBuy$415.00 ➝ $468.00Low
7/23/2020BTIG ResearchBoost Price TargetBuy$372.00 ➝ $475.00Low
7/23/2020CitigroupBoost Price TargetBuy$390.00 ➝ $471.00Low
7/23/2020Stifel NicolausBoost Price TargetHold ➝ Buy$370.00 ➝ $460.00Low
7/23/2020SVB LeerinkBoost Price TargetOutperform$365.00 ➝ $455.00Low
7/21/2020UBS GroupBoost Price TargetBuy$385.00 ➝ $440.00High
7/15/2020Cleveland ResearchUpgradeNeutral ➝ BuyLow
7/7/2020Needham & Company LLCBoost Price TargetBuy$383.00 ➝ $415.00Low
7/6/2020CowenReiterated RatingBuy$380.00Low
4/23/2020CitigroupBoost Price TargetBuy$365.00 ➝ $390.00High
4/23/2020SVB LeerinkBoost Price TargetOutperform$330.00 ➝ $365.00High
4/23/2020Needham & Company LLCBoost Price Target$341.00 ➝ $383.00High
4/22/2020Needham & Company LLCBoost Price TargetBuy$341.00 ➝ $383.00Medium
4/21/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$300.00 ➝ $340.00High
4/2/2020Stifel NicolausLower Price TargetBuy$345.00 ➝ $315.00Medium
3/30/2020Wells Fargo & CompanyLower Price TargetEqual Weight$345.00 ➝ $300.00Medium
3/20/2020CitigroupLower Price TargetBuy$390.00 ➝ $365.00Low
3/4/2020Robert W. BairdBoost Price TargetOutperform$340.00 ➝ $341.00High
2/24/2020ArgusReiterated RatingBuy ➝ Positive$370.00High
1/31/2020BTIG ResearchBoost Price TargetBuy ➝ In-Line$342.00 ➝ $372.00High
1/31/2020Robert W. BairdBoost Price TargetOutperform$319.00 ➝ $340.00High
1/31/2020Wells Fargo & CompanyLower Price TargetEqual Weight$350.00 ➝ $345.00High
1/31/2020Needham & Company LLCBoost Price TargetBuy$331.00 ➝ $341.00High
1/31/2020CitigroupBoost Price TargetBuy$380.00 ➝ $390.00High
1/22/2020Credit Suisse GroupInitiated CoverageNeutral$341.00Low
1/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$350.00Low
1/6/2020CitigroupInitiated CoverageBuy$380.00Low
1/6/2020CowenReiterated RatingOutperform$330.00 ➝ $365.00Medium
1/3/2020Needham & Company LLCInitiated CoverageStrong-Buy$271.00Medium
11/14/2019Stifel NicolausInitiated CoverageBuy$345.00Medium
11/14/2019Evercore ISIUpgradeOutperformHigh
10/24/2019Robert W. BairdBoost Price TargetOutperform$305.00 ➝ $319.00Low
10/23/2019JPMorgan Chase & Co.Boost Price TargetOverweight$315.00 ➝ $330.00Low
7/31/2019Credit Suisse GroupReiterated RatingBuy$310.00Low
7/25/2019Needham & Company LLCBoost Price TargetBuy ➝ Buy$315.00 ➝ $321.00Low
7/16/2019Needham & Company LLCDowngradeStrong-Buy ➝ Buy$315.00Low
7/15/2019BarclaysSet Price TargetBuy$330.00Medium
5/30/2019Wolfe ResearchInitiated CoverageOutperform ➝ OutperformLow
5/23/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$313.00 ➝ $315.00Low
5/23/2019BTIG ResearchBoost Price TargetAverage ➝ Buy$320.00Low
5/23/2019UBS GroupBoost Price TargetBuy$305.00 ➝ $320.00Low
5/1/2019ArgusBoost Price TargetBuy ➝ Buy$285.00 ➝ $310.00Low
4/22/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$271.00 ➝ $312.00Low
4/16/2019Bank of AmericaReiterated RatingBuy ➝ Buy$285.00 ➝ $300.00High
3/26/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$270.00 ➝ $288.00Low
3/26/2019BTIG ResearchBoost Price TargetBuy$310.00Low
3/25/2019UBS GroupBoost Price TargetBuy$305.00High
3/22/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$275.00 ➝ $300.00High
3/18/2019BarclaysBoost Price TargetOverweight ➝ Overweight$295.00 ➝ $300.00Low
1/31/2019BTIG ResearchBoost Price TargetBuy$290.00Medium
1/30/2019Robert W. BairdBoost Price TargetOutperform$264.00 ➝ $270.00Low
1/3/2019BarclaysBoost Price TargetOverweight ➝ Overweight$275.00 ➝ $280.00Low
1/2/2019Needham & Company LLCInitiated CoverageStrong-Buy ➝ Strong-Buy$271.00High
10/25/2018Morgan StanleyBoost Price TargetOverweight$254.00 ➝ $260.00Low
10/25/2018Robert W. BairdBoost Price TargetOutperform$256.00 ➝ $264.00Low
10/18/2018Cleveland ResearchDowngradeBuy ➝ NeutralMedium
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$242.00 ➝ $254.00High
10/10/2018CitigroupBoost Price TargetBuy ➝ Buy$260.00 ➝ $280.00High
10/9/2018UBS GroupInitiated CoverageBuy ➝ Buy$295.00Low
9/24/2018BarclaysBoost Price TargetOverweight ➝ Overweight$250.00 ➝ $275.00Low
9/17/2018The Goldman Sachs GroupDowngradeBuy ➝ NeutralMedium
7/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$233.00 ➝ $242.00Low
7/26/2018SVB LeerinkBoost Price TargetOutperform$239.00 ➝ $255.00Medium
7/26/2018JPMorgan Chase & Co.Reiterated RatingOverweight$300.00Medium
7/13/2018Morgan StanleyBoost Price TargetOverweight$230.00 ➝ $233.00Low
4/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$216.00 ➝ $230.00Low
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$228.00 ➝ $216.00Low
2/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$235.00 ➝ $250.00Low
2/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$223.00 ➝ $227.00Low
2/1/2018BarclaysBoost Price TargetOverweight ➝ Overweight$225.00 ➝ $245.00Low
2/1/2018SVB LeerinkReiterated RatingOutperform$200.00 ➝ $239.00Low
1/5/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$230.00Medium
1/3/2018Evercore ISIInitiated CoverageOutperform$220.00Medium
12/4/2017SVB LeerinkReiterated RatingOutperform$216.00 ➝ $200.00High
10/30/2017SVB LeerinkReiterated RatingBuyN/A
10/26/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$216.00 ➝ $226.00N/A
10/9/2017SVB LeerinkBoost Price TargetOutperform$190.00 ➝ $207.00N/A
9/28/2017Jefferies Financial GroupReiterated RatingHold$195.00Low
9/26/2017The Goldman Sachs GroupInitiated CoverageBuy$225.00Low
9/25/2017BarclaysReiterated RatingOverweight$200.00 ➝ $215.00Low
9/10/2017CowenReiterated RatingOutperform$200.00 ➝ $220.00Low
9/6/2017Morgan StanleyReiterated RatingOverweight ➝ Overweight$220.00Medium
9/1/2017CowenReiterated RatingBuy$200.00Low
8/22/2017ArgusReiterated RatingBuyMedium
7/21/2017Bank of AmericaReiterated RatingBuy$200.00 ➝ $210.00Low
7/20/2017Cleveland ResearchUpgradeNeutral ➝ BuyLow
7/17/2017BarclaysReiterated RatingOverweight$190.00 ➝ $200.00Low
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 ➝ $200.00Low
7/10/2017CitigroupReiterated RatingBuy$182.00 ➝ $201.00Low
6/10/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$200.00Low
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$194.00Low
5/17/2017Jefferies Financial GroupReiterated RatingHold$175.00Low
5/9/2017BarclaysReiterated RatingOverweight ➝ Overweight$175.00 ➝ $190.00Low
5/9/2017Bank of AmericaBoost Price TargetBuy$190.00 ➝ $200.00Low
4/29/2017CowenReiterated RatingOutperform$175.00 ➝ $185.00Low
4/28/2017Morgan StanleyBoost Price TargetOverweight$186.00 ➝ $192.00Low
4/28/2017Jefferies Financial GroupBoost Price TargetHold$160.00 ➝ $175.00Low
4/28/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$163.00 ➝ $188.00Low
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 ➝ $190.00Low
4/27/2017SVB LeerinkSet Price TargetBuy$187.00Low
4/26/2017BarclaysSet Price TargetBuy$175.00Low
3/29/2017Jefferies Financial GroupReiterated RatingHold$160.00Low
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 ➝ $162.00N/A
1/23/2017Jefferies Financial GroupLower Price TargetHold$163.00 ➝ $160.00N/A
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$163.00N/A
12/12/2016The Goldman Sachs GroupReiterated RatingConviction-Buy ➝ Conviction-Buy$170.00 ➝ $168.00N/A
11/20/2016SVB LeerinkReiterated RatingBuy$175.00N/A
11/10/2016SVB LeerinkInitiated CoverageOutperform$175.00N/A
10/7/2016Bank of AmericaSet Price TargetBuy$180.00N/A
9/27/2016UBS GroupReiterated RatingBuy$176.00N/A
9/22/2016JPMorgan Chase & Co.Initiated CoverageOverweight$180.00N/A
9/21/2016UBS GroupBoost Price TargetBuy$170.00 ➝ $176.00N/A
9/9/2016Cleveland ResearchDowngradeBuy ➝ NeutralN/A
8/4/2016Jefferies Financial GroupReiterated RatingHoldN/A
7/29/2016CitigroupBoost Price TargetBuy$160.00 ➝ $182.00N/A
7/28/2016MizuhoSet Price TargetBuy$170.00 ➝ $175.00N/A
(Data available from 7/26/2016 forward)
Thermo Fisher Scientific logo
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Read More

Today's Range

Now: $529.28
Low: $525.65
High: $532.99

50 Day Range

MA: $485.96
Low: $441.00
High: $532.26

52 Week Range

Now: $529.28
Low: $399.16
High: $533.15

Volume

34,433 shs

Average Volume

1,741,767 shs

Market Capitalization

$208.02 billion

P/E Ratio

26.65

Dividend Yield

0.20%

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Thermo Fisher Scientific?

The following Wall Street analysts have issued stock ratings on Thermo Fisher Scientific in the last year: Argus, Atlantic Securities, Bank of America Co., Barclays PLC, Benchmark Co., BTIG Research, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Evercore ISI, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Needham & Company LLC, Robert W. Baird, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for TMO.

What is the current price target for Thermo Fisher Scientific?

19 Wall Street analysts have set twelve-month price targets for Thermo Fisher Scientific in the last year. Their average twelve-month price target is $542.26, suggesting a possible upside of 2.5%. Stifel Nicolaus has the highest price target set, predicting TMO will reach $600.00 in the next twelve months. Argus has the lowest price target set, forecasting a price of $450.00 for Thermo Fisher Scientific in the next year.
View the latest price targets for TMO.

What is the current consensus analyst rating for Thermo Fisher Scientific?

Thermo Fisher Scientific currently has 1 hold rating and 18 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TMO will outperform the market and that investors should add to their positions of Thermo Fisher Scientific.
View the latest ratings for TMO.

What other companies compete with Thermo Fisher Scientific?

How do I contact Thermo Fisher Scientific's investor relations team?

Thermo Fisher Scientific's physical mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company's listed phone number is (781) 622-1000 and its investor relations email address is [email protected] The official website for Thermo Fisher Scientific is www.thermofisher.com.